CYTO - Altamira reports publication of positive results from NASAR clinical trial with Bentrio April, 24 2024 10:11 AM Altamira Therapeutics Ltd. 2024-04-24 10:11:05 ET More on Altamira Therapeutics Altamira stock rallies 44% on Univercells mRNA collaboration Seeking Alpha’s Quant Rating on Altamira Therapeutics Financial information for Altamira Therapeutics For further details see: Altamira reports publication of positive results from NASAR clinical trial with Bentrio